Pictet Asset Management (Switzerland)’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $84.6M | Buy |
928,624
+478,585
| +106% | +$43.6M | 0.1% | 214 |
|
|
2023
Q1 | $29.7M | Buy |
450,039
+4,334
| +1% | +$286K | 0.04% | 373 |
|
|
2022
Q4 | $23M | Sell |
445,705
-541,862
| -55% | -$28M | 0.03% | 416 |
|
|
2022
Q3 | $67.5M | Buy |
987,567
+9,909
| +1% | +$677K | 0.1% | 233 |
|
|
2022
Q2 | $44.2M | Buy |
977,658
+79,702
| +9% | +$3.6M | 0.06% | 302 |
|
|
2022
Q1 | $45.6M | Buy |
897,956
+251,597
| +39% | +$12.8M | 0.05% | 330 |
|
|
2021
Q4 | $30.6M | Buy |
+646,359
| New | +$30.6M | 0.03% | 434 |
|